Psychology
Attention Deficit
76%
Treatment
47%
Groups
45%
Depression
45%
Schizophrenia
35%
Caregiver
34%
Children
34%
Methylphenidate
27%
Assessment
27%
Adolescents
25%
Bipolar Disorder
23%
Health
20%
Rating Scale
17%
Meta-Analysis
17%
Anxiety
16%
Mood Disorder
14%
Dehydroepiandrosterone
14%
Questionnaires
13%
Interviews
13%
Validity
11%
Quality of Life
11%
Attention
11%
Patient with Attention Deficit Hyperactivity Disorder
10%
Systematic Literature Review
10%
Mental Health
9%
Cognition
9%
Depression
9%
Comorbidity
9%
Mood
8%
Parenting
8%
Gender Difference
7%
Research
7%
Cognitive Function
7%
Major Depression
7%
Cognitive Development
7%
Neurocognitive Function
6%
Depression Scale
6%
Hazard Ratio
6%
Psychiatric Disorder
6%
I-Disorder
6%
Intellectual Disabilities
6%
Behavior
6%
Intention
6%
Cognitive Impairment
6%
Psychotic Disorder
5%
Psychological Well-Being
5%
Alcohol
5%
Clinical Interview
5%
Oppositional Defiant Disorder
5%
Psychological Distress
5%
Medicine and Dentistry
Patient
90%
Attention Deficit Disorder
60%
Therapeutic Procedure
38%
Inpatient
37%
Child
36%
Symptom
31%
Age
22%
Methylphenidate
22%
Caregiver
18%
Follow up
17%
Patient with Attention Deficit Hyperactivity Disorder
14%
Family
13%
Anxiety
12%
Head and Neck Cancer
12%
Brain Derived Neurotrophic Factor
11%
Major Depressive Episode
11%
Diagnosis
11%
Serum
11%
Association
10%
Methamphetamine
10%
Cognition
10%
Bipolar Disorder
10%
Plasma
9%
Chronic Kidney Disease
9%
Mood Disorder
9%
Dextromethorphan
9%
Meta-Analysis
9%
Hospital
9%
Inflammation
8%
Drug Therapy
8%
Chemotherapeutic Agent
8%
Drug
8%
Placebo
8%
Testosterone
7%
Hospital Anxiety and Depression Scale
7%
Disease
7%
Health
7%
Sex Difference
7%
Recurrence Risk
7%
Cognitive Development
7%
Hemodialysis
7%
Opiate
7%
Adolescent
7%
Psychosis
6%
Prevalence
6%
Male
6%
Mental Health
6%
Analysis
6%
Amaurosis
6%
Biological Marker
6%
Neuroscience
Attention Deficit Hyperactivity Disorder
100%
Depression
41%
Bipolar II Disorder
33%
Bipolar Disorder
29%
Dementia Praecox
28%
Brain-Derived Neurotrophic Factor
28%
Methylphenidate
25%
Cognitive Function
24%
Polymorphism
22%
Dehydroepiandrosterone
16%
Cognition
16%
Aripiprazole
15%
Memantine
14%
Anxiety
12%
Major Depressive Disorder
12%
MicroRNA
12%
Genotype
11%
Gene
10%
Attention
10%
Meta-Analysis
10%
Protein
10%
Placebo
9%
Neurosteroid
9%
Dextromethorphan
9%
Tumor Necrosis Factor Alpha
9%
Comorbidity
9%
Antipsychotic
9%
Valproic Acid
8%
Cognitive Disorders
8%
Psychosis
8%
Methamphetamine
8%
Parkinson's Disease
7%
Fibrinogen
7%
Cortisol
7%
Intellectual Disability
6%
Brain
6%
Triacylglycerol
6%
Bipolar I Disorder
5%
Opioid
5%
Randomized Controlled Trial
5%
Ketamine
5%
Physical Dependence
5%
Testosterone
5%
Hyperactivity
5%
Sex Hormone
5%